0001104659-24-003050.txt : 20240110
0001104659-24-003050.hdr.sgml : 20240110
20240110182718
ACCESSION NUMBER: 0001104659-24-003050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240108
FILED AS OF DATE: 20240110
DATE AS OF CHANGE: 20240110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luo Mary Z.
CENTRAL INDEX KEY: 0001611156
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 24527562
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Jack Y.
CENTRAL INDEX KEY: 0001611157
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 24527563
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
tm241836-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-08
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001611156
Luo Mary Z.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
COO,Chief Scientist & Chairman
0001611157
Zhang Jack Y.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
CEO & Chief Scientific Officer
1
Common Stock
2024-01-08
4
S
0
18858
56.9818
D
1436744
D
Common Stock
2024-01-08
4
S
0
41282
58.2451
D
1395462
D
Common Stock
2024-01-08
4
S
0
37865
59.2405
D
1357597
D
Common Stock
2024-01-08
4
S
0
27563
59.9943
D
1330034
D
Common Stock
2024-01-08
4
S
0
4261
61.1927
D
1325773
D
Common Stock
2024-01-08
4
S
0
1663
61.8064
D
1324110
D
Common Stock
2024-01-08
4
S
0
2152
63.2662
D
1321958
D
Common Stock
2024-01-09
4
S
0
50678
56.7039
D
1271280
D
Common Stock
2024-01-09
4
S
0
31764
57.7028
D
1239516
D
Common Stock
2024-01-09
4
S
0
3714
58.3521
D
1235802
D
Common Stock
2078718
I
See footnote
Common Stock
6827679
I
See footnote
Common Stock
5000
I
See footnote
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.57 to $57.555, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.60 to $58.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.61 to $59.60, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.61 to $60.595, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.625 to $61.595, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.42, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.08 to $63.395, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.15 to $57.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.15 to $58.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.15 to $58.64, inclusive.
The securities are held of record by Jack Y. Zhang. The reporting persons are husband and wife.
The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
The shares are held of record by the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
/s/ Eva Wen, by power of attorney for Mary Z. Luo
2024-01-10
/s/ Eva Wen, by power of attorney for Jack Y. Zhang
2024-01-10